raloxifene hydrochloride has been researched along with Acute Kidney Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Concors, SJ; Ge, G; Hancock, WW; Hernandez, P; Levine, MH; O'Brien, C; Wang, Z | 1 |
| Eriguchi, M; Haruyama, N; Kitazono, T; Nakano, T; Tanaka, S; Taniguchi, M; Tsuruya, K; Yamada, S; Yoshida, H | 1 |
2 other study(ies) available for raloxifene hydrochloride and Acute Kidney Injury
| Article | Year |
|---|---|
The Selective Estrogen Receptor Modulator, Raloxifene, Is Protective Against Renal Ischemia-reperfusion Injury.
Topics: Acute Kidney Injury; Animals; Creatinine; Dimethyl Sulfoxide; Estrogens; Female; Fibrosis; Kidney; Mice; Mice, Inbred C57BL; Raloxifene Hydrochloride; Reperfusion Injury; Selective Estrogen Receptor Modulators | 2022 |
The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
Topics: Acid Phosphatase; Acute Kidney Injury; Adult; Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Resorption; Cinacalcet; Collagen Type I; Cross-Sectional Studies; Female; Humans; Hydroxycholecalciferols; Isoenzymes; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peptides; Peritoneal Dialysis; Raloxifene Hydrochloride; Regression Analysis; Tartrate-Resistant Acid Phosphatase | 2013 |